In vivo targeting of ADAM9 gene expression using lentivirus-delivered shRNA suppresses prostate cancer growth by regulating REG4 dependent cell cycle progression.

by Che-Ming Liu, Chia-Ling Hsieh, Yun-Chi He, Sen-Jei Lo, Ji-An Liang, Teng-Fu Hsieh, Sajni Josson, Leland W K Chung, Mien-Chie Hung, Shian-Ying Sung
Published 2013-01-01